Tag: Therapeutics

News

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson’s Disease Data Readout Targeted for First Half of 2027

August 6, 2026
Lunai Bioworks Inc.
No Comments

New BioSymetrics Inc. white paper and executed Master Collaboration Agreement establish an integrated roadmap spanning AI-driven patient stratification, human translational validation, biomarker development, and pharmaceutical…

Business

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 4, 2025
PTC Therapeutics, Inc.
No Comments

, /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Sept. 28, 2025, the company approved non-statutory stock options to purchase an aggregate…

News

STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer

May 28, 2025
STORM Therapeutics
No Comments

, /PRNewswire/ –Mindray(SZSE: 300760), de toonaangevende wereldwijde ontwikkelaar van technologieën voor de gezondheidszorg, lanceerde haaroplossing voor patiëntbewaking BeneVision V SeriestijdensEuroanaesthesia 2025in Lissabon. Aangedreven door een…